-
The president of the European Commission says the EU's new crown vaccination will be launched by the end of December
Time of Update: 2021-03-08
agreement with six pharmaceutical companies to order new crown vaccines, European Commission President Jean-Claude Jung said on the 25th, the European Union's new crown vaccination is expected to start by the end of December this year
-
New progress has been made in the study of the evolutionary history of the chinese meth plant system
Time of Update: 2021-03-08
respectively, and proposed the establishment of cross-provincial nature reserves and national parks in eastern China, so as to more systematically protect the higher systematic development diversity of the region, so that the early origin of the new
-
Chongqing 2015 will focus on the development of anti-corrosion coatings and other new materials products
Time of Update: 2021-03-08
screens, absorbent coatings, corrosive coatings, power batteries and other products; In the environmental protection industry, this year Chongqing will focus on promoting Yongchuan City Mineral Base, Dadukou Environmental Protection Science
-
China's independent research and development of new technologies to enable coronary heart disease diagnosis to achieve non-invasion
Time of Update: 2021-03-08
medical Shinkansen Coronary heart disease is the number one killer of human health, the fatality rate and incidence rate remain high. “ Coronary heart disease is high fatality rate
-
Pfizer filed a 4/6 inhibitor new adaptor listing application in China
Time of Update: 2021-03-08
In addition, in April 2019, Pybersili was approved by the FDA to be used in association with aromatase inhibitors or fluorovis groups to treat patients with breast cancer in men with HR-plus/HER2-advanced or metastasis.
-
Hydrogels open up new avenues for glare treatment
Time of Update: 2021-03-08
In the eyes of the glare, the main path is blocked, so in order to reduce the pressure, treatment is required to open a smaller path to allow water to flow out of the house.
-
2021 Tumor New Drug Data Card - Darotamin
Time of Update: 2021-03-08
(nmCRPC) with a high risk of metastasis. that the tumor has not spread to other parts of the body and is no longer effective for testosterone-lowering drugs or surgical treatments. Q4 treatment costs listed as a prostate cancer AR inhibitor
-
Are bacteria big or small? Scientists challenge two major rules to come up with new formulas
Time of Update: 2021-03-08
growth rate conditions, and the proposed quantitative formula also makes natural phenomena such as bacterial individual size and growth rate predictable, for example, when the bacterial growth rate and DNA replication cycle are known, the size
-
Yuan Longping's new three-year plan "kind" in the "heart"
Time of Update: 2021-03-08
and technological research plan, adhere to the combination of short-term benefits and long-term goals. For example, accelerate the ripe results, choose some innovative results, short-term breakthrough direction, promote the familiarization of major scientific
-
A new study by scientists has found that it's not just climate that affects mountain tree lines
Time of Update: 2021-03-08
Science and Technology Daily (Liu Xiaoxuan reporter Lu Chengguang) Recently, researchers at the Qinghai-Tibet Plateau have made important theoretical progress in the field of the driving mechanism of tree line change in the mountains
-
The new crown inactivated vaccine of Koxing Zhongwei, a pharmaceutical speed-reading agency, was approved for sale in China
Time of Update: 2021-03-08
the launch of an innovative prescription medical device developed by Signal Medical Technologies on February 6, the FDA announced that it had approved the launch of an innovative prescription medical device developed by Signifier Medical Technologies
-
Hundred-time Meishi Shiguibao Zeposia in the European Union formally applied for a new adaptive disorder
Time of Update: 2021-03-08
started the centralized review process. If approved, Zeposia will be the first oral acetaminophen-1-phosphoric acid (S1P) regulator for the treatment of ulcerative colitis (UC). This application is based on the results of the Key 3
-
Take stock | more than 20 new Chinese drugs that will be eligible for FDA orphan drugs by 2020
Time of Update: 2021-03-08
6, Drugs: Xindili monoanti-anti-research and development enterprises: Cinda biotherapic diseases: T-cell lymphoma, esophageal cancer Xindili mono-antibody as a PD-1 monoclonal antibody, in December 2018 was approved by China's State Drug Administration (NMPA) to treat recurrence/refractic classic Hodgkin lymphoma.
-
European Medicines Agency (EMA) Announces Summary of New Drug Authorizations for 2020 (II)
Time of Update: 2021-03-08
fusion, or patients with advanced non-small cell lung cancer who are ROS1-positive. company plans to submit long-term follow-up data for major studies that include the long-term effectiveness and safety of specific subgroups (older, female
-
New ideas for access to high-value innovative drug medical insurance under the multi-level guarantee framework
Time of Update: 2021-03-08
, with "heavy disease, good efficacy, high cost, large population" four characteristics. china, high-value innovative drug medical insurance access is facing the problem of sustainable development. 1. Access needs are urgent for patients
-
From drug-free to multiple treatments, 34 clinically urgently needed new drugs have been approved
Time of Update: 2021-03-08
addition, NMPA has approved a number of clinically urgent new drugs from abroad to bring innovative therapies to patients with multiple types of diseases.
-
12 new class 1 drug batch clinical, from Sanofi, Yingpai Pharmaceuticals and other companies | Cde...
Time of Update: 2021-03-08
May 2020, the drug has been approved clinically in the United States for the treatment of IDH1 mutations in solid tumors including advanced bile tube cancer, cartilage sarcoma and glioma.
-
Improve market share, paint brand building to go "new"
Time of Update: 2021-03-08
of the brand, but how can enterprises pull up the brand? In fact, the current consumer groups to 80-based, and brands are closely linked with consumers, therefore, paint enterprises with "new" operation, may be able to attract the attention
-
Virus mutation challenges the development of new crown drugs
Time of Update: 2021-03-08
CNBC reported on January 13th that Dave Rix, chief executive of Lilly, said a variant found in South Africa threatened to invalidate an antibody drug the company made.
-
Provincial new crown vaccine procurement catalogue published
Time of Update: 2021-03-08
. The price of the vaccine is 200 yuan / branch (bottle), 2 doses of a total of 400 yuan, and the service fee of 28 yuan per dose. It remains to be seen how the pricing and price negotiations in Jiangsu will go next.
